{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:23:08Z","timestamp":1782768188477,"version":"3.54.5"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301869\/2017-0"],"award-info":[{"award-number":["301869\/2017-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["312979\/2018-5"],"award-info":[{"award-number":["312979\/2018-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Human T lymphotropic virus 1 (HTLV-1) is a public health issue for most countries and imposes important consequences on patients' health and socioeconomic status. Brazil is one of the global leaders of the public health response to these viruses. The country has challenges to overcome to implement meaningful policies aiming to eliminate HTLV-1\/2. An analysis of strengths, weaknesses, opportunities, and threats (SWOT) for the implementation of public health policies on HTLV-1\/2 was performed. The strengths identified were the Brazilian Unified Health System (SUS); Brazilian expertise in public health programs successfully implemented; currently available policies targeting HTLV; and strong collaboration with researchers and patient's representative. Lack of awareness about HTLV, insufficient epidemiological data, lack of reference centers for patient care, insufficient availability of confirmatory tests, lack of universal antenatal screening, and absence of cost-effectiveness studies were identified as weaknesses. Some interesting opportunities included the increased interest from international organizations on HTLV, possibility of integrating HTLV into other programs, external funding for research, available online platforms, opportunity to acquire data from HTLV-1\/2 surveillance to gather epidemiological information, and HTLV policies that were implemented independently by states and municipalities. In addition to the COVID-19 pandemic, existing demands from different diseases, the country's demography and its marked sociocultural diversity and the volatility of the technical team working with HTLV-1\/2 at the Brazilian Ministry of Health are threats to the implementation of public policies on HTLV-1\/2. This SWOT analysis will facilitate strategic planning to allow continuous progress of the Brazilian response to HTLV-1\/2 infection.<\/jats:p>","DOI":"10.3389\/fmed.2022.859115","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T06:24:11Z","timestamp":1649312651000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of the Implementation of Public Health Policies on HTLV-1 in Brazil"],"prefix":"10.3389","volume":"9","author":[{"given":"Angelica Espinosa","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Rosadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane","family":"Assone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson Fernando Mendes","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlos Ros\u00e1rio","family":"Vallinoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"B1","first-page":"78","volume-title":"Human T-Lymphotropic Virus Type 1: Technical Report","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","article-title":"Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies","volume":"20","author":"Schierhout","year":"2019","journal-title":"Lancet Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0008761","DOI":"10.1371\/journal.pntd.0008761","article-title":"Health state utility values in people living with htlv-1 and in patients with ham\/tsp: The impact of a neglected disease on the quality of life","volume":"14","author":"Rosadas","year":"2020","journal-title":"PLoS Negl Trop Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"E164","DOI":"10.1016\/S2666-5247(21)00330-X","article-title":"Health inequities and HTLV-1","volume":"3","author":"Rosadas","year":"2022","journal-title":"Lancet Microbe."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0009717","DOI":"10.1371\/journal.pntd.0009717","article-title":"Blocking HTLV-1\/2 silent transmission in Brazil: current public health policies and proposal for additional strategies","volume":"15","author":"Rosadas","year":"2021","journal-title":"PLoS Negl Trop Dis."},{"key":"B7","first-page":"31","volume-title":"Inaugural Meeting of the Strategic and Technical Advisory Group on Disease Elimination","year":"2020"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0140-6736(14)61646-9","article-title":"Health-system reform and universal health coverage in Latin America","volume":"385","author":"Atun","year":"2015","journal-title":"Lancet (London, England)."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1001692","DOI":"10.1371\/journal.pmed.1001692","article-title":"Monitoring and evaluating progress towards Universal Health Coverage in Brazil","volume":"11","author":"Barreto","year":"2014","journal-title":"PLoS Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1377\/hlthaff.2016.0966","article-title":"Large reductions in amenable mortality associated with Brazil's primary care expansion and strong health governance","volume":"36","author":"Hone","year":"2017","journal-title":"Health Affairs (Project Hope)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1377\/hlthaff.2010.0251","article-title":"Major expansion of primary care in Brazil linked to decline in unnecessary hospitalization","volume":"29","author":"Macinko","year":"2010","journal-title":"Health Affairs (Project Hope)."},{"key":"B12","first-page":"132","article-title":"Twenty Years of Health System Reform in Brazil: An Assessment of the Sistema \u00danico de Sa\u00fade","author":"Gragnolati","year":"2013"},{"key":"B13","unstructured":"The Chalenges Faced by the National Health Services"},{"key":"B14","volume-title":"Portaria 1376 de 19\/11\/1993 - Minist\u00e9rio da Sa\u00fade","year":"1993"},{"key":"B15","volume-title":"PORTARIA No. 2600, DE 21 DE OUTUBRO DE 2009","year":"2009"},{"key":"B16","volume-title":"Protocolo de Uso Zidovudina para Tratamento do Adulto com Leucemia\/Linfoma Associado ao V\u00edrus HTLV-1","year":"2016"},{"key":"B17","first-page":"52","volume-title":"Guia de Manejo Cl\u00ednico do Paciente com HTLV","year":"2004"},{"key":"B18","first-page":"79","volume-title":"Guia de Manejo Cl\u00ednico da Infec\u00e7\u00e3o pelo HTLV","year":"2014"},{"key":"B19","article-title":"Sa\u00fade do Brasil","volume-title":"Guia de Manejo Cl\u00ednico da Infec\u00e7\u00e3o pelo HTLV","year":"2021"},{"key":"B20","volume-title":"SEI\/MS - 0022272097 - Nota Informativa- NOTA INFORMATIVA No 4\/2021-CGIST\/.DCCI\/SVS\/MS Disp\u00f5e sobre a recomenda\u00e7\u00e3o do medicamento cabergolina 0,5mg e da f\u00f3rmula l\u00e1ctea infantil na preven\u00e7\u00e3o da transmiss\u00e3o vertical do HIV e do HTLV","year":"2021"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2020605","DOI":"10.1590\/0037-8682-605-2020","article-title":"Brazilian protocol for sexually transmitted infections 2020: human T-cell lymphotropic virus (HTLV) infection","volume":"54","author":"Rosadas","year":"2021","journal-title":"Rev Soc Bras Med Trop."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e2020605","DOI":"10.1590\/S1679-497420200006000015.esp1","volume":"30","author":"Rosadas","year":"2021","journal-title":"Epidemiologia e servicos de saude."},{"key":"B23","unstructured":"Preval\u00eancia da Infec\u00e7\u00e3o por HTLV-1\/2 no Brasil\n            CGIST\/DDCI\/SVS C-G de V dasIST\n            RosadasC\n            Espinosa MirandaA\n            Utsch Gon\u00e7alvesD\n            Caterino-de-Ara\u00fajoA\n            AssoneT\n            IshakR\n          Boletim Epidemiol\u00f3gico.2020"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1705","DOI":"10.1371\/journal.pntd.0001705","article-title":"Living invisible: HTLV-1-infected persons and the lack of care in public health","volume":"6","author":"Zihlmann","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e00005419","DOI":"10.1590\/0102-311x00005419","article-title":"HTLV: uma infec\u00e7\u00e3o estigmatizante?","volume":"35","author":"Garcia IF da","year":"2019","journal-title":"Cadernos de Sa\u00fade P\u00fablica."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0242669","DOI":"10.1371\/journal.pone.0242669","article-title":"Qualitative evidence synthesis of values and preferences to inform infant feeding in the context of non-HIV transmission risk","volume":"15","author":"Carroll","year":"2020","journal-title":"PLoS One."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e00303420","DOI":"10.1590\/0102-311x00303420","volume":"37","author":"Garcia IF da","year":"2021","journal-title":"Cad Saude Publica."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12977-020-0512-z","article-title":"The challenge of describing the epidemiology of HTLV in the Amazon region of Brazil","volume":"17","author":"Ishak","year":"2020","journal-title":"Retrovirology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13023-021-01990-3","article-title":"Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy\/tropical spastic paraparesis: a nationwide registry study in Japan","volume":"16","author":"Iijima","year":"2021","journal-title":"Orphanet J Rare Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"20017","DOI":"10.2807\/ese.16.46.20017-en","article-title":"Recruiting individuals into the HTLV cohort study in the United Kingdom: clinical findings and challenges in the first six years, 2003 to 2009","volume":"16","author":"Brant","year":"2011","journal-title":"Euro Surveill."},{"key":"B31","unstructured":""},{"key":"B32","doi-asserted-by":"publisher","first-page":"e01752021","DOI":"10.1590\/0037-8682-0175-2021","article-title":"Laboratory diagnosis of human T-lymphotropic virus in Brazil: assays, flowcharts, challenges, and perspectives","volume":"54","author":"Caterino-de-Araujo","year":"2021","journal-title":"Revista da Sociedade Brasileira de Medicina Trop."},{"key":"B33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1473-3099(18)30735-7","article-title":"Towards the elimination of HTLV-1 infection in Japan","volume":"19","author":"Nishijima","year":"2019","journal-title":"Lancet Infect Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fmicb.2020.00595","article-title":"Nationwide antenatal human T-cell leukemia virus type-1 antibody screening in Japan","volume":"11","author":"Itabashi","year":"2020","journal-title":"Front Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/vox.12778","article-title":"The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1\/2) in South African blood donors","volume":"114","author":"Vermeulen","year":"2019","journal-title":"Vox Sang."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/bjh.15234","article-title":"Can we reduce the incidence of adult T-cell leukaemia\/lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United Kingdom","volume":"184","author":"Malik","year":"2019","journal-title":"Br J Haematol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/vox.12597","article-title":"Reconsideration of blood donation testing strategy for human T-cell lymphotropic virus in Australia","volume":"112","author":"Styles","year":"2017","journal-title":"Vox Sang."},{"key":"B38","unstructured":"2021"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12977-020-00546-w","article-title":"Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey","volume":"18","author":"Chang","year":"2021","journal-title":"Retrovirology."},{"key":"B40","volume-title":"PORTARIA N","year":"2020"},{"key":"B41","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0140-6736(18)31221-2","article-title":"Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the Global Burden of Disease Study 2016","volume":"392","year":"2018","journal-title":"Lancet."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2021.11.010","article-title":"Impact of COVID-19 on global burn care","author":"Laura","year":"2021","journal-title":"Burns."},{"key":"B43","doi-asserted-by":"publisher","first-page":"S1516","DOI":"10.1590\/1516-3180.2021.0496.23072021","article-title":"Hospitalization, mortality and public healthcare expenditure in Brazil during the COVID-19 crisis: vulnerabilities in the spotlight","volume":"15","author":"Nascimento IJB","year":"2021","journal-title":"S\u00e3o Paulo Med J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"100053","DOI":"10.1016\/j.jcvp.2021.100053","article-title":"Retrospective epidemiology of the SARS-CoV-2 (and COVID-19) epidemic among 27 Brazilian cities","volume":"1","author":"Lima","year":"2021","journal-title":"J Clin Virol Plus."},{"key":"B45","doi-asserted-by":"publisher","first-page":"106914","DOI":"10.1016\/j.ypmed.2021.106914","article-title":"Repercussions of the COVID-19 pandemic on preventive health services in Brazil","volume":"155","author":"de Oliveira","year":"2021","journal-title":"Preventive medicine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1099\/jmm.0.001466","article-title":"Effect of COVID-19 on vaccination coverage in Brazil","author":"Silveira","year":"2021","journal-title":"J Med Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0008922","DOI":"10.1371\/journal.pntd.0008922","article-title":"Challenges in establishing telehealth care during the COVID-19 pandemic in a neglected HTLV-1-infected population in northeastern Brazil","volume":"14","author":"Galv\u00e3o-Castro","year":"2020","journal-title":"PLoS Negl Trop Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.859115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T06:24:18Z","timestamp":1649312658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.859115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":47,"alternative-id":["10.3389\/fmed.2022.859115"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.859115","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"article-number":"859115"}}